Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.
Intrinsic and extrinsic control of oligodendrocyte development.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
Neuroinflammation: The role and consequences.
Cognitive impairment among different clinical courses of multiple sclerosis.
Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer Thickness in NMO Patients.
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies.
General Practitioner Preferences in Managing Care of Multiple Sclerosis Patients.
Lynoral: How To Order
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
[Affective and psychotic disorders in multiple sclerosis].
Pages
« first
‹ previous
…
325
326
327
328
329
330
331
332
333
…
next ›
last »